Cellebrite DI Ltd. (NASDAQ:CLBT) Sees Large Growth in Short Interest

Cellebrite DI Ltd. (NASDAQ:CLBT) was the recipient of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 1,170,000 shares, a growth of 13.6% from the December 15th total of 1,030,000 shares. Based on an average daily volume of 1,310,000 shares, the short-interest ratio is presently 0.9 days. Approximately 1.4% of the company’s shares are short sold.

Institutional Trading of Cellebrite DI

Hedge funds and other institutional investors have recently modified their holdings of the business. Quarry LP bought a new stake in shares of Cellebrite DI in the third quarter worth $27,000. Point72 Asia Singapore Pte. Ltd. increased its position in shares of Cellebrite DI by 59.6% in the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,724 shares of the company’s stock worth $33,000 after purchasing an additional 1,017 shares during the last quarter. Advisors Asset Management Inc. raised its stake in shares of Cellebrite DI by 130.5% in the 3rd quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company’s stock valued at $52,000 after purchasing an additional 1,742 shares in the last quarter. Pathway Financial Advisers LLC lifted its position in shares of Cellebrite DI by 1,583.8% during the third quarter. Pathway Financial Advisers LLC now owns 4,378 shares of the company’s stock worth $74,000 after purchasing an additional 4,118 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Cellebrite DI in the second quarter worth about $71,000. 45.88% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages recently weighed in on CLBT. TD Cowen increased their target price on Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a research report on Monday, September 23rd. JPMorgan Chase & Co. raised their price objective on Cellebrite DI from $22.00 to $24.00 and gave the stock an “overweight” rating in a report on Monday, December 16th. Craig Hallum boosted their target price on Cellebrite DI from $23.00 to $24.00 and gave the stock a “buy” rating in a report on Thursday, November 7th. Finally, Needham & Company LLC raised their price target on shares of Cellebrite DI from $17.00 to $21.00 and gave the company a “buy” rating in a report on Thursday, November 7th. Eight investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $20.57.

Cellebrite DI Price Performance

Cellebrite DI stock opened at $22.78 on Monday. Cellebrite DI has a one year low of $8.23 and a one year high of $23.50. The stock’s 50 day moving average price is $20.76 and its 200 day moving average price is $17.64.

Cellebrite DI (NASDAQ:CLBT) last posted its earnings results on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.05. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. The business had revenue of $106.90 million for the quarter, compared to analysts’ expectations of $102.06 million. During the same period in the previous year, the company posted $0.09 earnings per share. The business’s revenue for the quarter was up 27.0% compared to the same quarter last year. As a group, research analysts predict that Cellebrite DI will post 0.32 earnings per share for the current year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.